| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Increase in cash and cash equivalents | -1,219,677 | 141,131 |
| Cash and cash equivalents at beginning of period | 4,301,945 | - |
| Cash and cash equivalents at end of period | 3,082,268 | - |
Bluejay Diagnostics, Inc. (BJDX)
Bluejay Diagnostics, Inc. (BJDX)